Compounds for proteasome enzyme inhibition

Details for Australian Patent Application No. 2005271232 (hide)

Owner Proteolix, Inc.

Inventors Smyth, Mark S.; Laidig, Guy J.

Agent Shelston IP

Pub. Number AU-B-2005271232

PCT Pub. Number WO2006/017842

Priority 60/599,401 06.08.04 US; 60/610,001 14.09.04 US; 11/106,879 14.04.05 US

Parent 2005238445

Filing date 8 August 2005

Wipo publication date 16 February 2006

Acceptance publication date 5 July 2012

International Classifications

C07K 5/087 Peptides having up to four amino acids in a fully defined sequence

A61K 38/06 Medicinal preparations containing peptides - Tripeptides

A61K 38/07 Medicinal preparations containing peptides - Tetrapeptides

C07K 5/02 Peptides having up to four amino acids in a fully defined sequence

C07K 5/10 Peptides having up to four amino acids in a fully defined sequence

C07K 5/103 Peptides having up to four amino acids in a fully defined sequence

C07K 5/107 Peptides having up to four amino acids in a fully defined sequence

Event Publications

1 March 2007 PCT application entered the National Phase

  PCT publication WO2006/017842 Priority application(s): WO2006/017842

5 July 2012 Application Accepted

  Published as AU-B-2005271232

1 November 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005271241-Dispersion management in optical networks using a differential phase shift keying modulation format

2005271224-Street lamp